Miniatura

Fitxers

668625.pdf (302.64 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2016-11-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/109682

Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas.

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1515/cclm-2015-1048

Resum

BACKGROUND: BRAF and NRAS mutation detection is crucial for advanced melanoma treatment. Our aim was to evaluate how different characteristics from formalin-fixed paraffin-embedded (FFPE) samples, age of the block or DNA concentration could influence the success of BRAF and NRAS mutational screening. METHODS: DNA was obtained from 144 FFPE samples (62 primary melanoma, 43 sentinel lymph nodes [SLN] and 39 metastasis). BRAF and NRAS were sequenced by Sanger sequencing. RESULTS: Complete sequencing results were obtained from 75% (108/144) of the samples, and at least one gene was sequenced in 89% (128/144) of them. BRAF was mutated in 55% (29/53) and NRAS in 11% (5/45) of the primary melanomas sequenced. DNA concentration correlated with the tumor area used for DNA extraction (mm2) (adj p-value<0.01, r=0.73). The age of the block did not affect sequencing success. In 60% of samples kept for more than 10 years, both BRAF and NRAS were successfully sequenced. CONCLUSIONS: Preserving sufficient tumor area in FFPE blocks is important. It is necessary to keep the FFPE blocks, no matter their age, as they are necessary to decide the best treatment for the melanoma patient.

Matèries

Melanoma, Tumors, Mutació (Biologia)

Matèries (anglès)

Melanoma, Tumors, Mutation (Biology)

Citació

Col·leccions

Articles publicats en revistes (Fonaments Clínics)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

POTRONY MATEU, Míriam, BADENAS ORQUIN, Celia, NAERHUYZEN, Bénédicte, AGUILERA, Paula, PUIG BUTILLÉ, Joan anton, TELL MARTÍ, Gemma, DÍAZ LORCA, Maria alba, CARRERA ÁLVAREZ, Cristina, ALÓS I HERNÁNDEZ, Llúcia, DELAHAYE, Nicolas, MALVEHY, J. (josep), PUIG I SARDÀ, Susana. Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas.. _Clinical Chemistry and Laboratory Medicine_. 2016. Vol. 54, núm. 11, pàgs. 1733-1738. [consulta: 13 de gener de 2026]. ISSN: 1434-6621. [Disponible a: https://hdl.handle.net/2445/109682]

Exportar metadades

JSON - METS

Compartir registre